Serabelisib

Generic Name
Serabelisib
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C19H17N5O3
CAS Number
1268454-23-4
Unique Ingredient Identifier
43J9Q56T3W
Background

Serabelisib is under investigation in clinical trial NCT02625259 (A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants).

Associated Conditions
-
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath